4D Molecular Therapeutics (FDMT) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free FDMT Stock Alerts $25.70 +0.06 (+0.23%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 4D Molecular Therapeutics Short Interest DataCurrent Short Volume9,620,000 sharesPrevious Short Volume9,830,000 sharesChange Vs. Previous Month-2.14%Dollar Volume Sold Short$230.21 millionShort Interest Ratio / Days to Cover11.1Last Record DateApril 30, 2024Outstanding Shares51,157,000 sharesPercentage of Shares Shorted18.80%Today's Trading Volume397,446 sharesAverage Trading Volume434,694 sharesToday's Volume Vs. Average91% Short Selling 4D Molecular Therapeutics ? Sign up to receive the latest short interest report for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFDMT Short Interest Over TimeFDMT Days to Cover Over TimeFDMT Percentage of Float Shorted Over Time Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. 4D Molecular Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,620,000 shares $230.21 million -2.1%N/A11.1 $23.93 4/15/20249,830,000 shares $258.04 million +5.5%N/A8.3 $26.25 3/31/20249,320,000 shares $296.94 million +9.7%N/A8 $31.86 3/15/20248,500,000 shares $267.84 million +1.9%N/A7.7 $31.51 2/29/20248,340,000 shares $233.69 million +18.1%N/A7.8 $28.02 2/15/20247,060,000 shares $195.49 million +83.9%N/A7.1 $27.69 Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,840,000 shares $66.24 million +33.3%N/A4.3 $17.25 1/15/20242,880,000 shares $54.14 million -10.6%N/A7.7 $18.80 12/31/20233,220,000 shares $65.24 million -18.1%N/A8.8 $20.26 12/15/20233,930,000 shares $69.80 million +9.2%N/A10.8 $17.76 11/30/20233,600,000 shares $45.79 million -4.5%N/A10.6 $12.72 11/15/20233,770,000 shares $41.70 million +7.4%N/A11.2 $11.06 10/31/20233,510,000 shares $37.70 million -14.4%N/A10.6 $10.74 10/15/20234,100,000 shares $42.89 million +4.3%N/A13 $10.46 9/30/20233,930,000 shares $50.03 million +6.5%N/A13.6 $12.73 9/15/20233,690,000 shares $57.42 million +3.4%N/A12.3 $15.56 8/31/20233,570,000 shares $58.12 million No ChangeN/A9.4 $16.28 8/15/20233,570,000 shares $59.48 million +15.5%N/A8.6 $16.66 7/31/20233,090,000 shares $56.55 million -0.6%N/A6.5 $18.30 7/15/20233,110,000 shares $58.84 million -11.4%N/A5.3 $18.92 6/30/20233,510,000 shares $63.43 million +2.6%N/A5.5 $18.07 6/15/20233,420,000 shares $71.82 million +10.0%N/A5.4 $21.00 5/31/20233,110,000 shares $57.10 million +4.7%N/A5.2 $18.36 5/15/20232,970,000 shares $52.93 million +4.6%N/A5.4 $17.82 4/30/20232,840,000 shares $51.15 million -10.1%N/A5.6 $18.01 4/15/20233,160,000 shares $51.10 million +1.3%N/A8 $16.17 3/31/20233,120,000 shares $53.63 million +19.5%N/A8.8 $17.19 3/15/20232,610,000 shares $45.34 million +23.7%N/A7.6 $17.37 2/28/20232,110,000 shares $40.60 million -5.4%N/A6.3 $19.24 2/15/20232,230,000 shares $41.19 million +2.8%N/A6.1 $18.47 1/31/20232,170,000 shares $45.68 million -3.6%N/A4.5 $21.05 1/15/20232,250,000 shares $49.57 million +8.7%N/A4.4 $22.03 12/30/20222,070,000 shares $45.97 million +11.9%N/A3.9 $22.21 12/15/20221,850,000 shares $42.72 million -19.2%N/A3.2 $23.09 11/30/20222,290,000 shares $55.35 million -15.2%N/A4.2 $24.17 11/15/20222,700,000 shares $50.46 million -6.9%N/A5.5 $18.69 10/31/20222,900,000 shares $25.11 million -1.7%N/A9.1 $8.66 10/15/20222,950,000 shares $20.74 million +87.9%N/A10.6 $7.03 9/30/20221,570,000 shares $12.62 million +7.5%N/A6.3 $8.04 9/15/20221,460,000 shares $13.49 million -2.7%N/A7.6 $9.24The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide FDMT Short Interest - Frequently Asked Questions What is 4D Molecular Therapeutics' current short interest? Short interest is the volume of 4D Molecular Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 9,620,000 shares of FDMT short. Learn More on 4D Molecular Therapeutics' current short interest. What is a good short interest ratio for 4D Molecular Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FDMT shares currently have a short interest ratio of 11.0. Learn More on 4D Molecular Therapeutics's short interest ratio. Is 4D Molecular Therapeutics' short interest increasing or decreasing? 4D Molecular Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 9,620,000 shares, a decline of 2.1% from the previous total of 9,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 4D Molecular Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to 4D Molecular Therapeutics: Vir Biotechnology, Inc. (6.63%), Tarsus Pharmaceuticals, Inc. (20.27%), Cullinan Oncology, Inc. (10.23%), Neumora Therapeutics, Inc. (12.27%), Scholar Rock Holding Co. (16.78%), ADMA Biologics, Inc. (3.82%), BioCryst Pharmaceuticals, Inc. (16.30%), Autolus Therapeutics plc (1.32%), Inhibrx, Inc. (4.19%), Fusion Pharmaceuticals Inc. (4.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short 4D Molecular Therapeutics stock? Short selling FDMT is an investing strategy that aims to generate trading profit from 4D Molecular Therapeutics as its price is falling. FDMT shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 4D Molecular Therapeutics? A short squeeze for 4D Molecular Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FDMT, which in turn drives the price of the stock up even further. How often is 4D Molecular Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FDMT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Vir Biotechnology Short Interest Tarsus Pharmaceuticals Short Interest Cullinan Oncology Short Interest Neumora Therapeutics Short Interest Scholar Rock Short Interest ADMA Biologics Short Interest BioCryst Pharmaceuticals Short Interest Autolus Therapeutics Short Interest Inhibrx Short Interest Fusion Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FDMT) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingElon to Transform U.S. Economy? Porter & Company